These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 20099040)
1. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Maduekwe UN; Lauwers GY; Fernandez-Del-Castillo C; Berger DL; Ferguson CM; Rattner DW; Yoon SS Ann Surg Oncol; 2010 May; 17(5):1267-77. PubMed ID: 20099040 [TBL] [Abstract][Full Text] [Related]
2. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes. Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011 [TBL] [Abstract][Full Text] [Related]
3. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma. Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280 [TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system. Bouliaris K; Rachiotis G; Diamantis A; Christodoulidis G; Polychronopoulou E; Tepetes K Eur J Surg Oncol; 2017 Jul; 43(7):1350-1356. PubMed ID: 28433495 [TBL] [Abstract][Full Text] [Related]
5. Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. Pedrazzani C; Sivins A; Ancans G; Marrelli D; Corso G; Krumins V; Roviello F; Leja M World J Surg; 2010 Jan; 34(1):85-91. PubMed ID: 20020295 [TBL] [Abstract][Full Text] [Related]
6. What is the role of nodal ratio as a prognostic factor for gastric cancer nowadays? Comparison with new TNM staging system and analysis according to the number of resected nodes. Aurello P; Catracchia V; Petrucciani N; D'Angelo F; Leonardo G; Picchetto A; Antolino L; Magistri P; Terrenato I; Lauro A; Ramacciato G Am Surg; 2013 May; 79(5):483-91. PubMed ID: 23635583 [TBL] [Abstract][Full Text] [Related]
7. Lymphadenectomy in patients with gastric cancer. A critical review. Nitti D; Marchet A; Olivieri M; Ambrosi A; Mencarelli R; Farinati F; Belluco C; Lise M Suppl Tumori; 2003; 2(5):S35-8. PubMed ID: 12914388 [TBL] [Abstract][Full Text] [Related]
8. Topographic lymph node staging system shows prognostic superiority compared to the 8th edition of AJCC TNM in gastric cancer. A western monocentric experience. Lauricella S; Caricato M; Mascianà G; Carannante F; Carnazza M; Bonaccorso A; Angeletti S; Ciccozzi M; Coppola R; Capolupo GT Surg Oncol; 2020 Sep; 34():223-233. PubMed ID: 32869748 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer. Hou Y; Wang X; Chen J World J Surg Oncol; 2018 Oct; 16(1):198. PubMed ID: 30286762 [TBL] [Abstract][Full Text] [Related]
10. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes. Volpe CM; Driscoll DL; Douglass HO Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793 [TBL] [Abstract][Full Text] [Related]
11. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970 [TBL] [Abstract][Full Text] [Related]
12. The lymph node ratio as a prognostic factor for gastric cancer. Nelen SD; van Steenbergen LN; Dassen AE; van der Wurff AA; Lemmens VE; Bosscha K Acta Oncol; 2013 Nov; 52(8):1751-9. PubMed ID: 23317142 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. Hyung WJ; Noh SH; Yoo CH; Huh JH; Shin DW; Lah KH; Lee JH; Choi SH; Min JS World J Surg; 2002 Mar; 26(3):323-9. PubMed ID: 11865369 [TBL] [Abstract][Full Text] [Related]
14. Lymph node ratio-based staging system for esophageal squamous cell carcinoma. Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the metastatic lymph node ratio in gastric cancer patients. Fukuda N; Sugiyama Y; Midorikawa A; Mushiake H World J Surg; 2009 Nov; 33(11):2378-82. PubMed ID: 19760318 [TBL] [Abstract][Full Text] [Related]
16. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? Biondi A; D'Ugo D; Cananzi FC; Papa V; Borasi A; Sicoli F; Degiuli M; Doglietto G; Persiani R Eur J Surg Oncol; 2015 Jun; 41(6):779-86. PubMed ID: 25899981 [TBL] [Abstract][Full Text] [Related]
17. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer. Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506 [TBL] [Abstract][Full Text] [Related]
18. A novel lymph node staging system for gastric cancer including modified Union for cancer Control/American Joint Committee on cancer and Japanese Gastric Cancer Association criteria. Gong Y; Pan S; Wang X; Zhu G; Xu H; Zhu Z Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e27-e32. PubMed ID: 32631708 [TBL] [Abstract][Full Text] [Related]
19. D2 lymph node dissection improves staging in patients with gastric adenocarcinoma. Putchakayala K; Difronzo LA Am Surg; 2011 Oct; 77(10):1326-9. PubMed ID: 22127080 [TBL] [Abstract][Full Text] [Related]
20. Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patients. Yamashita H; Deng J; Liang H; Seto Y Surgery; 2017 Jun; 161(6):1588-1596. PubMed ID: 28111043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]